GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Not yet recruiting · NCT07668765 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity | Anorectal Diseases, Body Weight, Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Fissure in Ano, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anus disorder, cardiovascular disorder, constipation disorder, diarrheal disease, digestive system disorder, hemorrhoid, intestinal disorder, morbid obesity, nutritional disorder, obesity disorder, overnutrition, rectal disorder, vascular disorder | Not yet recruiting | Not stated | 2026-06-25 | NCT07668765 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gazi University | 105 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gazi University Faculty of Medicine | Ankara | Turkey (Türkiye) | 4 |